John M. Prager, Jennifer J. Liang, et al.
AMIA Joint Summits on Translational Science 2017
We assessed the effect of surgery on survival from stage I non-small-cell lung cancer based on data collected in these screening programs. The majority of patients diagnosed in each program were treated by surgical resection, but 5 percent of the Sloan-Kettering group, 21 percent of the Hopkins group and 11 percent of the Mayo group failed to receive surgical treatment. Approximately 70 percent of the stage I patients in each program who were treated surgically survived more than five years, but there were only two five-year survivors among those who did not have surgery. We conclude that patients with lung cancers detected in stage I by chest x-ray film and treated surgically have a good chance of remaining free of disease for many years. Those stage I lung cancers which are not resected progress and lead to death within five years. Therefore, every effort should be made to detect and treat lung cancer early in high-risk populations.
John M. Prager, Jennifer J. Liang, et al.
AMIA Joint Summits on Translational Science 2017
F. James Rohlf
Mathematical Biosciences
Elif K. Eyigoz, Melody Courson, et al.
Cortex
Huajun Chen, Guotong Xie
Expert Opinion on Drug Discovery